Delivery Order SPE2DB20D2014-SPE2DB24FC77B
- Not listed
- This federal contract award is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $5,308.79 and is a firm-fixed-price delivery order with an ultimate completion date of July 22, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
- This federal contract award is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,035.16 and a period of performance through March 4, 2025. It is a firm-fixed-price delivery order contract awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not designated as a set-aside and appears to be part...
- This federal contract award is for the delivery of AIMOVIG 140 MG/ML autoinjector medical supplies to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor that serves numerous government agencies. The firm-fixed-price delivery order has a ceiling value of $2,713.59 and a completion date of September 27, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
- This federal contract award is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $13,170.36 firm fixed-price delivery order has an ultimate completion date of August 16, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the...
- The federal contract award is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 2, 2024 with a ceiling value of $6,434.16. This is a firm fixed-price delivery order contract with an ultimate completion date of August 5, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a...
- This federal contract award is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $11,144.64 and a completion date of December 27, 2023. It is a firm fixed-price delivery order contract, with no...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of AIMOVIG 140 MG/ML AUTOINJECTOR medical products. The award has a ceiling value of $5,431.44 and was issued as a delivery order under an Indefinite Delivery Contract (IDC) that the DLA Troop Support Medical has with AmerisourceBergen, valued at up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a...
- This federal contract award is for the delivery of the pharmaceutical product AIMOVIG 140 MG/ML AUTOINJECTORML, with a ceiling value of $4,825.38. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of February 4, 2025. The contract is not designated as a...
- This federal contract award is for the delivery of AIMOVIG 70 MG/ML AUTOINJECTORML, a pharmaceutical product, to the Defense Logistics Agency (DLA) on a firm fixed price basis. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company that serves as a prime contractor for various federal agencies, including the Department of Defense (DoD) and Department of Veterans Affairs (VA). The contract, valued at $1,807.64, has a period of performance through July...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML. The $20,031.72 firm-fixed-price delivery order has an ultimate completion date of October 8, 2024. This contract award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, that enables the government to...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB24FC77BDelivery Order
This federal contract award is for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, to the Defense Logistics Agency (DLA) under a Firm Fixed Price delivery order. The contract has a ceiling value of $32,699.62 and an ultimate completion date of August 16, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and the contract is not set aside. This contract is likely part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure essential pharmaceutical and medical supplies from Amerisourcebergen to support military treatment programs and facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $32.7k | 8/15/24 |